NCT06984133Recruiting
Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
Evaluating the Effectiveness of a Structured Educational Program on Glycemic Control in Adolescents With Type 1 Diabetes: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 22 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Type 1 diabetes is becoming more common in Kuwaiti and Arab adolescents. Many young people with this condition struggle to keep their blood glucose levels under control, which can lead to diabetes-related complications and affect their quality of life. The goal of this clinical trial is to evaluate the effectiveness of a structured educational program on glycemic control among Arab adolescents with type 1 diabetes aged 11 to 14 years. Participants will be randomly assigned to one of two groups. The intervention group will receive the structured education program, and the control group will continue with standard care. All participants will undergo assessments that include: * collecting demographic and diabetes management data * measuring weight and height * measuring HbA1c levels and lipid profile * filling out questionnaires on quality of life, carbohydrate and insulin dosing knowledge, physical activity * collecting dietary intake * providing AGP report Participants in the intervention group will additionally be required to: * attend the program for 4 consecutive days, one day for parents and three days for children * fill out 3-day food diary records during the program * attend a refresher course after 6 months Participants in the control group will have the opportunity to participate in the program after approximately six months.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- First submitted
- 14 May 2025
- Start date
- 18 May 2025
- Primary completion date
- 18 May 2028
- Lead sponsor
- Dasman Diabetes Institute
- Diseases
- Type 1 diabetes
- NCT number
- NCT06984133
What you commit to
- Study type: Interventional
- Planned participants: 128
- From 18 May 2025 to the primary completion date, 18 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Attendance at any diabetes education or carbohydrate counting programs within the six months preceding the study.
Other
- Presence of learning disabilities or any known psychological issues.
Who the study is looking for
- Arab adolescents
- Males and females aged 11 to 14 years.
- Have been diagnosed with type 1 diabetes for at least 6 months.
- Wearing a continuous glucose monitor (CGM).
- Individuals and their parents must be able to join the entire duration of the study.
- Individuals and their parents must voluntarily provide consent and assent.
Age in the registry: 11 years to 14 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dasman Diabetes Institute Coordinator of this site? Confirm its status | Kuwait City | Kuwait | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.